CN105358548A - 二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法 - Google Patents
二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法 Download PDFInfo
- Publication number
- CN105358548A CN105358548A CN201480027307.9A CN201480027307A CN105358548A CN 105358548 A CN105358548 A CN 105358548A CN 201480027307 A CN201480027307 A CN 201480027307A CN 105358548 A CN105358548 A CN 105358548A
- Authority
- CN
- China
- Prior art keywords
- alternatively
- general formula
- alkyl
- yuan
- integer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
Abstract
Description
化合物的编号 | pk1 | pk2 |
2 | 7.11(1) | 11.27(2) |
3 | 6.88(1) | 11.27(2) |
11 | 7.16(1) | 11.89(2) |
12 | 7.13(1) | 11.95(2) |
Claims (78)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811167688.7A CN109096199B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167650.XA CN109336819B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167661.8A CN109096198B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811168167.3A CN109134378B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167690.4A CN109096200B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2013116822 | 2013-04-12 | ||
RU2013116822A RU2665688C2 (ru) | 2013-04-12 | 2013-04-12 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
PCT/RU2014/000265 WO2014168523A1 (ru) | 2013-04-12 | 2014-04-10 | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
Related Child Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811167688.7A Division CN109096199B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167650.XA Division CN109336819B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167661.8A Division CN109096198B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811168167.3A Division CN109134378B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167690.4A Division CN109096200B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105358548A true CN105358548A (zh) | 2016-02-24 |
Family
ID=51689820
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811168167.3A Active CN109134378B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167650.XA Active CN109336819B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167661.8A Active CN109096198B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167688.7A Active CN109096199B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167690.4A Active CN109096200B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201480027307.9A Pending CN105358548A (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法 |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811168167.3A Active CN109134378B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167650.XA Active CN109336819B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167661.8A Active CN109096198B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167688.7A Active CN109096199B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
CN201811167690.4A Active CN109096200B (zh) | 2013-04-12 | 2014-04-10 | 二羧酸双酰胺衍生物、其用途和基于其的药物组合物 |
Country Status (26)
Country | Link |
---|---|
US (3) | US20160031858A1 (zh) |
EP (1) | EP2985284B1 (zh) |
JP (1) | JP6760837B2 (zh) |
KR (1) | KR102218134B1 (zh) |
CN (6) | CN109134378B (zh) |
AU (1) | AU2014251443C1 (zh) |
BR (1) | BR112015025675B1 (zh) |
CA (1) | CA2909411C (zh) |
CY (1) | CY1125062T1 (zh) |
DK (1) | DK2985284T3 (zh) |
EA (6) | EA202092452A3 (zh) |
ES (1) | ES2904568T3 (zh) |
HK (1) | HK1221223A1 (zh) |
HR (1) | HRP20220103T1 (zh) |
HU (1) | HUE057209T2 (zh) |
IL (1) | IL242029B (zh) |
LT (1) | LT2985284T (zh) |
MX (2) | MX2015014213A (zh) |
PL (1) | PL2985284T3 (zh) |
PT (1) | PT2985284T (zh) |
RS (1) | RS62889B1 (zh) |
RU (1) | RU2665688C2 (zh) |
SG (2) | SG11201508342RA (zh) |
SI (1) | SI2985284T1 (zh) |
UA (1) | UA119748C2 (zh) |
WO (1) | WO2014168523A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110087650A (zh) * | 2017-05-26 | 2019-08-02 | 制药有限责任公司 | 新的谷氨酰胺酰基环化酶抑制剂及其在治疗多种疾病中的用途 |
CN112334464A (zh) * | 2018-05-24 | 2021-02-05 | 过敏制药有限责任公司 | 丙二酸的双酰胺衍生物用于在人和动物中治疗变应性疾病和其他疾病的用途 |
CN113227075A (zh) * | 2018-10-29 | 2021-08-06 | 制药有限责任公司 | 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
CN110229140B (zh) * | 2013-04-12 | 2022-06-10 | 制药有限责任公司 | 戊二酰亚胺衍生物、其用途、基于所述衍生物的药物组合物及戊二酰亚胺衍生物的制备方法 |
RU2647438C2 (ru) * | 2015-05-27 | 2018-03-15 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей |
RU2662559C1 (ru) * | 2017-10-27 | 2018-07-26 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый ингибитор глутаминилциклаз и его применение для лечения заболеваний легких и дыхательных путей |
RU2665633C1 (ru) * | 2017-05-26 | 2018-09-03 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Новый ингибитор глутаминилциклаз и его применение |
US11479532B2 (en) | 2017-06-23 | 2022-10-25 | University Of South Florida | 5-aminolevulinate synthase inhibitors and methods of use thereof |
RU2745265C2 (ru) * | 2019-09-12 | 2021-03-22 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
WO2021049980A1 (ru) * | 2019-09-12 | 2021-03-18 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новые составы для лечения и профилактики вирусных заболеваний |
RU2746692C1 (ru) * | 2020-04-14 | 2021-04-19 | Общество С Ограниченной Ответственностью "Валента - Интеллект" | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний |
WO2023177328A1 (en) | 2022-03-17 | 2023-09-21 | Treamid Therapeutics Gmbh | Bisamide derivative of dicarboxylic acid for use in restoring the external respiratory function after coronavirus infection |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6169759A (ja) * | 1984-09-14 | 1986-04-10 | Agency Of Ind Science & Technol | タンパク質の架橋反応用修飾剤及びそれを用いる方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6344567A (ja) * | 1986-08-08 | 1988-02-25 | Shikoku Chem Corp | 新規なイミダゾール系ジアミド化合物、該化合物の合成方法および該化合物を有効成分とするポリエポキシ樹脂硬化剤 |
IL86131A0 (en) * | 1987-04-24 | 1988-11-15 | Boehringer Ingelheim Kg | Benzo-and thieno-3,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
AU2001283740A1 (en) * | 2000-08-17 | 2002-02-25 | University Of British Columbia | Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours |
RU2287524C1 (ru) * | 2005-03-31 | 2006-11-20 | ООО "Фарминтерпрайсез" | Аспартильные производные гистамина, способ их получения, фармацевтическая композиция и их применение в качестве модуляторов активности ферментов антиоксидантной защиты |
RU2335495C2 (ru) * | 2005-06-15 | 2008-10-10 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | N-ацильные производные аминокислот, их фармацевтически приемлевые соли, фармацевтическая композиция и применение в качестве гиполипидемических средств |
CN1919884A (zh) * | 2005-08-26 | 2007-02-28 | 建筑技术研究有限公司 | 基于氧化烯二醇烯基醚和不饱和二羧酸衍生物的共聚物 |
CA2629814C (en) * | 2005-11-14 | 2013-12-31 | Genentech, Inc. | Bisamide inhibitors of hedgehog signaling |
EP1884515A1 (en) * | 2006-07-31 | 2008-02-06 | Laboratorios del Dr. Esteve S.A. | Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
JP6079148B2 (ja) * | 2012-11-07 | 2017-02-15 | Jsr株式会社 | 液晶配向剤、液晶配向膜及び液晶表示素子 |
RU2665688C2 (ru) * | 2013-04-12 | 2018-09-04 | Общество С Ограниченной Ответственностью "Фарминтерпрайсез" | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения |
JP6169759B1 (ja) * | 2016-07-11 | 2017-07-26 | 株式会社山寿セラミックス | 弾性表面波素子用基板及びその製造方法 |
-
2013
- 2013-04-12 RU RU2013116822A patent/RU2665688C2/ru active
-
2014
- 2014-04-10 CN CN201811168167.3A patent/CN109134378B/zh active Active
- 2014-04-10 RS RS20220090A patent/RS62889B1/sr unknown
- 2014-04-10 CN CN201811167650.XA patent/CN109336819B/zh active Active
- 2014-04-10 SI SI201431938T patent/SI2985284T1/sl unknown
- 2014-04-10 UA UAA201510873A patent/UA119748C2/uk unknown
- 2014-04-10 EA EA202092452A patent/EA202092452A3/ru unknown
- 2014-04-10 PL PL14782759T patent/PL2985284T3/pl unknown
- 2014-04-10 BR BR112015025675-9A patent/BR112015025675B1/pt active IP Right Grant
- 2014-04-10 EP EP14782759.6A patent/EP2985284B1/en active Active
- 2014-04-10 AU AU2014251443A patent/AU2014251443C1/en active Active
- 2014-04-10 CA CA2909411A patent/CA2909411C/en active Active
- 2014-04-10 CN CN201811167661.8A patent/CN109096198B/zh active Active
- 2014-04-10 EA EA202190775A patent/EA202190775A1/ru unknown
- 2014-04-10 CN CN201811167688.7A patent/CN109096199B/zh active Active
- 2014-04-10 EA EA202190774A patent/EA202190774A3/ru unknown
- 2014-04-10 LT LTEPPCT/RU2014/000265T patent/LT2985284T/lt unknown
- 2014-04-10 SG SG11201508342RA patent/SG11201508342RA/en unknown
- 2014-04-10 WO PCT/RU2014/000265 patent/WO2014168523A1/ru active Application Filing
- 2014-04-10 DK DK14782759.6T patent/DK2985284T3/da active
- 2014-04-10 JP JP2016507513A patent/JP6760837B2/ja active Active
- 2014-04-10 MX MX2015014213A patent/MX2015014213A/es unknown
- 2014-04-10 KR KR1020157032328A patent/KR102218134B1/ko active IP Right Grant
- 2014-04-10 CN CN201811167690.4A patent/CN109096200B/zh active Active
- 2014-04-10 EA EA201992275A patent/EA039440B1/ru unknown
- 2014-04-10 SG SG10202008505VA patent/SG10202008505VA/en unknown
- 2014-04-10 EA EA202092453A patent/EA202092453A3/ru unknown
- 2014-04-10 EA EA201501014A patent/EA036961B1/ru unknown
- 2014-04-10 HU HUE14782759A patent/HUE057209T2/hu unknown
- 2014-04-10 PT PT147827596T patent/PT2985284T/pt unknown
- 2014-04-10 CN CN201480027307.9A patent/CN105358548A/zh active Pending
- 2014-04-10 ES ES14782759T patent/ES2904568T3/es active Active
- 2014-04-10 HR HRP20220103TT patent/HRP20220103T1/hr unknown
-
2015
- 2015-10-08 MX MX2020013371A patent/MX2020013371A/es unknown
- 2015-10-09 US US14/879,648 patent/US20160031858A1/en not_active Abandoned
- 2015-10-12 IL IL242029A patent/IL242029B/en active IP Right Grant
-
2016
- 2016-08-08 HK HK16109432.9A patent/HK1221223A1/zh unknown
-
2021
- 2021-11-18 US US17/530,143 patent/US20220324843A1/en active Pending
-
2022
- 2022-02-03 CY CY20221100101T patent/CY1125062T1/el unknown
- 2022-12-21 US US18/086,141 patent/US20230203016A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6169759A (ja) * | 1984-09-14 | 1986-04-10 | Agency Of Ind Science & Technol | タンパク質の架橋反応用修飾剤及びそれを用いる方法 |
Non-Patent Citations (5)
Title |
---|
ANIL GUPTA ET AL.: "Lipophilic complexones. Part 6. Synthesis of di- and tri-armed ligands containing pyridine and imidazole moieties", 《JOURNAL OF CHEMISCAL RESEARCH SYNOPSES》 * |
GILLES FERRY ET AL.: "A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects", 《EUROPEAN JOURNAL OF PHARMACOLOGY》 * |
MARC BEBAN ET AL.: "Preparation of an Imidazole-Conjugated Oligonucleotide", 《BIOCONJUGATE CHEMISTRY》 * |
MIKHAIL A.PODYMINOGIN ET AL.: "Synthetic RNA-cleaving molecules mimicking ribonuclease A active center. Design and cleavage of Trna transcripts", 《NUCLEIC ACIDS RESEARCH》 * |
TADEUSZ JULIUSZ BURAKOWSKI ET AL.: "Preparation of certain bis-compounds derived from β-(2-thienyl)ethylamine and β-(2-thienyl)isopropyllamine", 《ACTA POLONIAE PHARMACEUTICA》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110087650A (zh) * | 2017-05-26 | 2019-08-02 | 制药有限责任公司 | 新的谷氨酰胺酰基环化酶抑制剂及其在治疗多种疾病中的用途 |
US11845740B2 (en) | 2017-05-26 | 2023-12-19 | LTD “Valenta-Intellekt” | Glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases |
CN110087650B (zh) * | 2017-05-26 | 2024-03-22 | 瓦伦塔有限责任公司 | 新的谷氨酰胺酰基环化酶抑制剂及其在治疗多种疾病中的用途 |
CN112334464A (zh) * | 2018-05-24 | 2021-02-05 | 过敏制药有限责任公司 | 丙二酸的双酰胺衍生物用于在人和动物中治疗变应性疾病和其他疾病的用途 |
CN112334464B (zh) * | 2018-05-24 | 2023-11-24 | 瓦伦塔有限责任公司 | 丙二酸的双酰胺衍生物用于在人和动物中治疗变应性疾病和其他疾病的用途 |
CN113227075A (zh) * | 2018-10-29 | 2021-08-06 | 制药有限责任公司 | 用于产生n,n’-双[2-(1h-咪唑-4-基)乙基]丙二酰胺的新方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105358548A (zh) | 二羧酸双酰胺衍生物、其用途、基于其的药物组合物和用于生产二羧酸双酰胺衍生物的方法 | |
CN100379737C (zh) | 作为髓过氧化物酶抑制剂的硫代黄嘌呤衍生物 | |
US9827244B2 (en) | Cap/endo dual inhibitors and their use in the treatment, amelioration or prevention of a viral disease | |
IE920409A1 (en) | Complexing agents | |
JP2018502121A (ja) | トリフルオロアセトヒドラジド類化合物及びその調製方法並びに製薬における応用 | |
RU2725881C2 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе, способы его получения | |
RU2725770C2 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе, способы его получения | |
RU2719464C2 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе, способы его получения | |
RU2709529C1 (ru) | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения | |
RU2815401C2 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе, способы его получения | |
US20230099089A1 (en) | Antiviral substances with a wide spectrum of activity | |
RU2721421C2 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе, способы его получения | |
CN103083313B (zh) | 一种取代吡咯色原酮类化合物在制备治疗5型磷酸二酯酶相关疾病的药物中的应用 | |
WO2011057580A1 (zh) | 有机二羧酸和其盐及其制备方法 | |
EP3383863A1 (en) | Isoindoline derivatives | |
EA043024B1 (ru) | Производное бисамидов дикарбоновых кислот и способы его получения | |
EA045515B1 (ru) | Производные бисамидов дикарбоновых кислот, их применение, фармацевтическая композиция на их основе, способы их получения | |
EA043680B1 (ru) | Производное бисамидов дикарбоновых кислот, его применение, фармацевтическая композиция на его основе | |
EA045675B1 (ru) | Способы получения бисамида дикарбоновой кислоты | |
EA043025B1 (ru) | Производное бисамида дикарбоновой кислоты и способы его получения | |
CN116768857A (zh) | Ezh2/hdac双靶点抑制剂及其制备方法和医药用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1221223 Country of ref document: HK |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Berlin Applicant after: Treamid Therapeutics GmbH Address before: Berlin Applicant before: Treamid Therapeutics GmbH |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180930 Address after: Berlin Applicant after: Treamid Therapeutics GmbH Address before: Moscow Applicant before: OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU "PHARMENTERPRISES" |
|
AD01 | Patent right deemed abandoned | ||
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20190326 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1221223 Country of ref document: HK |